Verastem | VSTM - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -6.66B 3.39B 2026-03
Alaunos Therapeutics USD 1.29M 865K 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
Curis USD 5.46M 19.45M 2025-12
Cytokinetics USD -826.57M 166.94M 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
Incyte USD 5.62B 455.37M 2026-03
Laboratory Of America USD 8.73B 108.8M 2026-03
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Roche Holding CHF 33.8B 758M 2025-12
TG Therapeutics USD 583.13M 64.89M 2026-03
Verastem USD 57.2M 72.72M 2025-12